What are the latest advances in Paget's Disease?

Recent advances in Paget’s Disease of bone focus on optimizing bisphosphonate therapy, exploring targeted monoclonal antibodies, and identifying the genetic pathways that drive excessive bone remodeling. While no cure currently exists, ongoing research is refining precision treatment strategies to manage bone pain, prevent skeletal deformities, and reduce the risk of secondary complications.

What are the most promising research directions for Paget’s Disease?

Modern research into Paget’s Disease is shifting toward understanding the complex interplay between genetic predisposition and environmental triggers, such as viral infections. Scientists are investigating the RANK/RANKL/OPG pathway, which is central to the overactive osteoclasts seen in Paget’s Disease. Researchers are also evaluating whether early intervention with potent bisphosphonates can alter the long-term progression of the condition before significant bone deformity occurs.

Are there new treatments for Paget’s Disease?

While bisphosphonates remain the standard of care for Paget’s Disease, clinical interest has turned toward alternative therapies for patients who are intolerant to these medications. Current efforts include:

• Biologics: Investigating RANK-ligand inhibitors, such as denosumab, for patients with refractory Paget’s Disease.


• Precision Dosing: Utilizing specific biomarkers, such as serum alkaline phosphatase (ALP) levels, to personalize treatment frequency.


• Surgical Innovations: Advances in orthopedic surgery for Paget’s Disease patients, including improved joint replacement techniques for pagetic bone.

How can patients participate in Paget’s Disease research?

Clinical trials are essential for moving science forward. Patients can search for current studies on ClinicalTrials.gov by using the search term "Paget's disease of bone." It is important to remember that clinical research is a long-term process, and while we are seeing more interest in rare diseases, not every trial will result in a new treatment.

Next steps

• Consult an endocrinologist or rheumatologist who specializes in metabolic bone disorders.


• Monitor your alkaline phosphatase (ALP) levels regularly as directed by your physician.


• Connect with others at DiseaseMaps.org to share experiences and stay updated on community-led initiatives.


• Discuss potential clinical trial eligibility with your healthcare provider.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Paget disease of bone.


• Orphanet: Paget disease of bone (ORPHA:676).


• Paget’s Association: Research and support for Paget’s Disease patients.


• ClinicalTrials.gov: Current registered studies for Paget’s Disease of bone.